Arrowhead Pharmaceuticals

$56.78
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.98 (+3.62%) Today
+$0.06 (+0.11%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell ARWR and other stocks, options, and ETFs commission-free!

About ARWR

Arrowhead Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops medicines that treat intractable diseases by silencing the genes that cause them. Read More The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA. The listed name for ARWR is Arrowhead Pharmaceuticals, Inc. Common Stock.

Employees
134
Headquarters
Pasadena, California
Founded
1989
Market Cap
5.80B
Price-Earnings Ratio
Dividend Yield
Average Volume
1.52M
High Today
$58.50
Low Today
$54.50
Open Price
$54.79
Volume
2.05M
52 Week High
$73.72
52 Week Low
$19.51

Collections

ARWR News

BenzingaOct 15

Why Arrowhead Pharmaceuticals Is Trading Higher Today

Arrowhead Pharmaceuticals (NASDAQ: ARWR) shares are trading higher on Thursday on news that Vertex Pharmaceuticals discontinued its trial of a drug candidate in

ARWR Earnings

-$0.20
-$0.04
$0.13
$0.29
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q4 2020
Estimated
per share
Actual
Expected Nov 25, After Hours

You May Also Like